The company said, “For the fiscal year ending December 31, 2025, the Company now expects total revenue to grow 20% to $734 million compared to the previous expectation of $732 million. This includes surgical revenue of $658 million and EOS revenue of $76 million. The Company now expects non-GAAP adjusted EBITDA of approximately $78 million compared to the previous expectation of $75 million.”
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATEC:
- Is ATEC a Buy, Before Earnings?
- Unusually active option classes on open April 15th
- Alphatec Holdings: Strategic Growth and Resilience Amid Economic Pressures with a Buy Rating
- Alphatec Holdings Implements Executive Salary Conversion Plan
- Alphatec Holdings: Strong Growth Potential and Undervalued Buy Opportunity